NYSE:A - Agilent Technologies Stock Price, Forecast & News

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies declared a quarterly dividend on Wednesday, November 20th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.18 per share on Wednesday, January 22nd. This represents a $0.72 annualized dividend and a dividend yield of 0.80%. The ex-dividend date is Monday, December 30th. This is an increase from Agilent Technologies's previous quarterly dividend of $0.16. View Agilent Technologies' Dividend History.

Agilent Technologies announced that its Board of Directors has initiated a stock buyback program on Monday, November 19th 2018, which allows the company to repurchase $1,750,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 8.8% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its stock is undervalued.

Agilent Technologies Inc (NYSE:A) released its earnings results on Monday, November, 25th. The medical research company reported $0.89 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.86 by $0.03. The medical research company had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.33 billion. Agilent Technologies had a net margin of 20.74% and a return on equity of 20.13%. The business's revenue for the quarter was up 5.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.81 EPS. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Agilent Technologies.

Agilent Technologies issued an update on its FY20 earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of $3.38-3.43 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.44. The company issued revenue guidance of $5.50-5.55 billion, compared to the consensus revenue estimate of $5.55 billion.

13 Wall Street analysts have issued 1-year target prices for Agilent Technologies' shares. Their forecasts range from $76.00 to $100.00. On average, they expect Agilent Technologies' stock price to reach $85.31 in the next year. This suggests that the stock has a possible downside of 5.3%. View Analyst Price Targets for Agilent Technologies.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.

Press coverage about A stock has been trending somewhat negative recently, according to InfoTrie. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Agilent Technologies earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media coverage about the medical research company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Agilent Technologies.

Agilent Technologies saw a decrease in short interest in December. As of December 31st, there was short interest totalling 4,660,000 shares, a decrease of 9.2% from the December 15th total of 5,130,000 shares. Based on an average trading volume of 1,570,000 shares, the days-to-cover ratio is presently 3.0 days. Approximately 1.5% of the shares of the stock are sold short. View Agilent Technologies' Current Options Chain.

Some companies that are related to Agilent Technologies include Thermo Fisher Scientific (TMO), Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include AbbVie (ABBV), NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), Netflix (NFLX), Walt Disney (DIS), Boeing (BA), Paypal (PYPL), Intel (INTC) and Broadcom (AVGO).

Agilent Technologies' stock is owned by many different of retail and institutional investors. Top institutional shareholders include LGT Capital Partners LTD. (0.19%), Calamos Advisors LLC (0.16%), Hexavest Inc. (0.15%), Hahn Capital Management LLC (0.12%), Commerzbank Aktiengesellschaft FI (0.06%) and Artemis Investment Management LLP (0.05%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Boston Trust Walden Corp, Hahn Capital Management LLC, Sciencast Management LP, Calamos Advisors LLC, Commerzbank Aktiengesellschaft FI and IFM Investors Pty Ltd. Company insiders that have sold Agilent Technologies company stock in the last year include Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

A stock was purchased by a variety of institutional investors in the last quarter, including Hexavest Inc., Artemis Investment Management LLP, PGGM Investments, LGT Capital Partners LTD., Johanson Financial Advisors Inc., DNB Asset Management AS, AE Wealth Management LLC and Fruth Investment Management. View Insider Buying and Selling for Agilent Technologies.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of A stock can currently be purchased for approximately $90.12.

Agilent Technologies has a market capitalization of $27.95 billion and generates $5.16 billion in revenue each year. The medical research company earns $1.07 billion in net income (profit) each year or $3.11 on an earnings per share basis. Agilent Technologies employs 16,300 workers across the globe.View Additional Information About Agilent Technologies.

The official website for Agilent Technologies is http://www.agilent.com/.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 800-227-9770 or via email at [email protected]